The efficient processes we apply in manufacturing and our commitment to ensure our customers receive the highest quality product have been recognised in the form of ISO9001 accreditation from BSI.
We have released a multi-purpose block for use with Her-2, ER and PR. The product is available in a 5-core format that offers a full dynamic range of expression for the 3 biomarkers, or a 2-core format that offers positive and negative control. As with all of our analyte controls, these can be purchased as pre-cut slides or as blocks to suit your workflow.
We have received SMART Award funding for a Proof of Market study to carry out market analysis as we look to expand our product range.
EML4-ALK Analyte Controls Released
Our ALK control contains two cell lines that demonstrate positive and negative expression of EML4-ALK. There are two formats available: control slides [HCL007](x2)[HCL008](x5) and control blocks [HCL009].
After the release of our first product and the positive reception it has received, we turned our attention toward developing analyte controls for assays that we have identified a clinical need for. With two more product lines approaching commercialization and the uptake we are seeing with our HPV analyte controls around the world, we decided it was necessary to expand.
As a result of this we have moved to a larger laboratory that offers a superior workflow and more efficient processing. Combined with the addition of some new equipment that allows us to bring more processes in-house, we believe we have the necessary means to meet the type of demand we expect when our next products come to market. If you have an unmet need in your laboratory or require a contract service please feel free to contact us.
Our list of distributors throughout Europe is expanding. HistoCyte products are now available to purchase from Immuno Diagnostic Oy in Finland and Biosystems Switzerland AG. If you are interested in distributing our products then please contact us at info@histocyte.com.
Quality and Confidence in Tissue Diagnostics by Keith Miller of UKNEQAS